Cargando…

Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors

PURPOSE: Report 5-year outcomes of patients receiving anti-vascular endothelial growth factor (VEGF) for the treatment of macular oedema secondary to retinal vein occlusion (RVO. METHODS: Retrospective review of eyes with RVO which initiated anti-VEGF treatment. Data including age, gender, visual ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spooner, Kimberly, Fraser-Bell, Samantha, Hong, Thomas, Chang, Andrew A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440600/ https://www.ncbi.nlm.nih.gov/pubmed/30997407 http://dx.doi.org/10.1136/bmjophth-2018-000249

Ejemplares similares

Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion
por: Spooner, Kimberly, et al.
Publicado: (2020)

Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions
por: Spooner, Kimberly, et al.
Publicado: (2020)

Optical-coherence tomography angiography and ultrawide-field angiography findings in eyes with refractory macular edema secondary to retinal vein occlusion switched to aflibercept: A subanalysis from a 48-week prospective study
por: Spooner, Kimberly, et al.
Publicado: (2020)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim, Moosang
Publicado: (2016)

Improving blood flow in occluded veins to reduce anti-vascular endothelial growth factor injections for branch retinal vein occlusion
por: Maeno, Takatoshi, et al.
Publicado: (2023)

Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy
por: Shchuko, Andrey G, et al.
Publicado: (2015)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
por: Hunt, Adrian Robert, et al.
Publicado: (2023)

Significant Correlation between Retinal Venous Tortuosity and Aqueous Vascular Endothelial Growth Factor Concentration in Eyes with Central Retinal Vein Occlusion
por: Yasuda, Shunsuke, et al.
Publicado: (2015)

Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
por: Fujikawa, Masato, et al.
Publicado: (2013)

Evaluation of Systemic Endothelial Dysfunction in Retinal Vein Occlusions
por: Bozkurt, Erdinc, et al.
Publicado: (2022)

Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year
por: Song, Shuang, et al.
Publicado: (2021)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2014)

A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Huang, Peirong, et al.
Publicado: (2013)

Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
por: Nixon, Donald R, et al.
Publicado: (2021)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2023)

Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
por: Modi, Yasha S., et al.
Publicado: (2023)

Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009)

Choroidal Vascularity Index in Central and Branch Retinal Vein Occlusion
por: Loiudice, Pasquale, et al.
Publicado: (2022)

Central retinal vein occlusion and branch retinal vein occlusion in the same eye
por: Sundar, M Dheepak, et al.
Publicado: (2019)

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
por: Nishida, Akihiro, et al.
Publicado: (2017)

Effects of apelin and vascular endothelial growth factor on central retinal vein occlusion in monkey eyes intravitreally injected with bevacizumab: a preliminary study
por: Zhao, Tong, et al.
Publicado: (2011)

Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion
por: Hwang, De-Kuang, et al.
Publicado: (2020)

Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)

Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment
por: Yang, Kai-Bo, et al.
Publicado: (2021)

Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study
por: Lee, Wan-Ju Annabelle, et al.
Publicado: (2023)

Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion
por: Chung, Yoo-Ri, et al.
Publicado: (2023)

Central retinal vein occlusion resulting from anomalous retinal vascular anatomy in a 24-year-old man
por: Kavoussi, Shaheen C, et al.
Publicado: (2015)

Retinal Artery and Vein Occlusions Successfully Treated with Hyperbaric Oxygen
por: Johnson, Daniel R., et al.
Publicado: (2019)

Inflammation in Retinal Vein Occlusion
por: Deobhakta, Avnish, et al.
Publicado: (2013)

A rare case having hemi-retinal artery occlusion in one eye and hemi-retinal vein occlusion in the other: Diverse manifestations of retinal vascular occlusion
por: Agarwal, Pulak, et al.
Publicado: (2019)

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
por: Gale, Richard, et al.
Publicado: (2021)

Arm-to-retina time predicts visual outcome of anti-vascular endothelial growth factor treatment for macular edema due to central retinal vein occlusion
por: Takei, Tatsuhiko, et al.
Publicado: (2022)

Analyze of factors and prognosis of eyes lost to follow-up in retinal vein occlusive disease patients receiving anti-vascular endothelial growth factor therapy
por: Huang, Xiaoying, et al.
Publicado: (2023)

Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion
por: Avrutsky, Maria I., et al.
Publicado: (2020)

Combined central retinal vein occlusion and branch retinal artery occlusion
por: Goel, Sugandha, et al.
Publicado: (2018)

Asymptomatic occlusive retinal vasculitis in newly diagnosed active tuberculosis
por: Bartimote, Christopher, et al.
Publicado: (2021)

Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins
por: Fraenkl, Stephan A., et al.
Publicado: (2010)

Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion
por: Cho, Bum-Joo, et al.
Publicado: (2019)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada, Hideaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bu7vuplhhnkvad3rsa74363lde